Dejan Radakovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Dejan Radakovic has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
Khaled Hamouda
6 shared publicationsIvan Aleksic
5 shared publicationsKiril Penov
4 shared publications- Kiril Penov
Department of Thoracic and Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany
4 shared publications Constanze Bening
Department of Thoracic and Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany
3 shared publications- Ivan Aleksic
Department of Thoracic and Cardiovascular Surgery, University Hospital Würzburg, Würzburg, Germany
3 shared publications
Latest Publications
- Open Access
- 1 September 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (9) , 6416-6424
Heart support crossroads: aortic Impella 5.5 implantation compared to conventional axillary approach in combined use of extracorporeal membrane oxygenation and Impella (ECMELLA) setting
Background: Postcardiotomy shock, often necessitates advanced mechanical circulatory support. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and the Impella 5.5 device are crucial for hemodynamic stabilization. This study evaluates the efficacy and safety of direct aortic cannulation versus axillary artery surgical cut-down for Impella 5.5 implantation in postcardiotomy shock patients. Methods: A retrospective analysis was conducted on 24 patients with postcardiotomy shock at the University Hospital of Würzburg from January 2023 to August 2024. Patients were divided into two groups: 12 underwent axillary artery implantation of the Impella 5.5 device, and 12 received the device via direct aortic implantation, including those with central combined use of extracorporeal membrane oxygenation and Impella (ECMELLA) setting. The aim was to assess the comparative efficacy and safety of direct aortic cannulation compared to axillary artery surgical cut-down. Results: Both techniques effectively stabilized cardiac function, with significant improvements in cardiac output and hemodynamic stability. Intensive care unit (ICU) stays were similar (axillary: 16.5±13.2 days; aortic: 14.5±13.5 days; P=0.72). Re-exploration rates for bleeding and in-hospital mortality rates were comparable (axillary: 41.7%, aortic: 58.3%; P=0.41). However, cardiopulmonary bypass (CPB) time was longer in the axillary group (247.8±145.3 minutes) compared to the aortic group (137.3±77.2 minutes; P=0.03). Conclusions: Both axillary and aortic cannulation techniques for Impella 5.5 implantation are effective for managing postcardiotomy shock, even in the ECMELLA setting. Direct aortic cannulation offers shorter CPB times, allows for chest closure enhancing procedural efficiency and safety, providing a practical and flexible option for various clinical scenarios.
- 1 September 2025
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 17 (9) , 6416-6424
Open AccessHeart support crossroads: aortic Impella 5.5 implantation compared to conventional axillary approach in combined use of extracorporeal membrane oxygenation and Impella (ECMELLA) setting
Background: Postcardiotomy shock, often necessitates advanced mechanical circulatory support. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) and the Impella 5.5 device are crucial for hemodynamic stabilization. This study evaluates the efficacy and safety of direct aortic cannulation versus axillary artery surgical cut-down for Impella 5.5 implantation in postcardiotomy shock patients. Methods: A retrospective analysis was conducted on 24 patients with postcardiotomy shock at the University Hospital of Würzburg from January 2023 to August 2024. Patients were divided into two groups: 12 underwent axillary artery implantation of the Impella 5.5 device, and 12 received the device via direct aortic implantation, including those with central combined use of extracorporeal membrane oxygenation and Impella (ECMELLA) setting. The aim was to assess the comparative efficacy and safety of direct aortic cannulation compared to axillary artery surgical cut-down. Results: Both techniques effectively stabilized cardiac function, with significant improvements in cardiac output and hemodynamic stability. Intensive care unit (ICU) stays were similar (axillary: 16.5±13.2 days; aortic: 14.5±13.5 days; P=0.72). Re-exploration rates for bleeding and in-hospital mortality rates were comparable (axillary: 41.7%, aortic: 58.3%; P=0.41). However, cardiopulmonary bypass (CPB) time was longer in the axillary group (247.8±145.3 minutes) compared to the aortic group (137.3±77.2 minutes; P=0.03). Conclusions: Both axillary and aortic cannulation techniques for Impella 5.5 implantation are effective for managing postcardiotomy shock, even in the ECMELLA setting. Direct aortic cannulation offers shorter CPB times, allows for chest closure enhancing procedural efficiency and safety, providing a practical and flexible option for various clinical scenarios.
- 7 April 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 71 (11) , 897-904
From Imaging to Insight: Sarcopenia as a Marker of Venoarterial Extracorporeal Membrane Oxygenation Mortality in Postcardiotomy Shock
Identifying risk factors for mortality in veno-arterial extracorporeal membrane oxygenation (VA-ECMO) patients with postcardiotomy shock is challenging due to numerous influencing factors. This study investigates the role of sarcopenia in outcomes for these patients. We retrospectively analyzed 433 patients who underwent ECMO implantation at our institution between 2012 and 2023. Among those with VA-ECMO for postcardiotomy shock, 99 had preoperative computed tomography (CT) scans. We measured the psoas muscle area at the L3–L4 vertebra and the pectoralis muscle area at the level of the left common carotid artery. The primary endpoints were identifying mortality risk factors and assessing survival and weaning success in relation to sarcopenia. We measured 66 psoas and 98 pectoralis muscle areas, identifying 34 sarcopenic (34.3%) and 65 nonsarcopenic (65.7%) patients. Baseline characteristics were similar between groups, except for age. Mortality was significantly higher in the sarcopenic group (85.3% vs. 66.2%; p = 0.042). Multivariable regression analysis identified continuous renal replacement therapy and sarcopenia as independent predictors of mortality. Sarcopenia, as indicated by psoas or pectoralis muscle area, is a significant predictor of increased mortality following VA-ECMO implantation, suggesting its potential use for enhanced risk stratification.
- 7 April 2025
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 71 (11) , 897-904
From Imaging to Insight: Sarcopenia as a Marker of Venoarterial Extracorporeal Membrane Oxygenation Mortality in Postcardiotomy Shock
Identifying risk factors for mortality in veno-arterial extracorporeal membrane oxygenation (VA-ECMO) patients with postcardiotomy shock is challenging due to numerous influencing factors. This study investigates the role of sarcopenia in outcomes for these patients. We retrospectively analyzed 433 patients who underwent ECMO implantation at our institution between 2012 and 2023. Among those with VA-ECMO for postcardiotomy shock, 99 had preoperative computed tomography (CT) scans. We measured the psoas muscle area at the L3–L4 vertebra and the pectoralis muscle area at the level of the left common carotid artery. The primary endpoints were identifying mortality risk factors and assessing survival and weaning success in relation to sarcopenia. We measured 66 psoas and 98 pectoralis muscle areas, identifying 34 sarcopenic (34.3%) and 65 nonsarcopenic (65.7%) patients. Baseline characteristics were similar between groups, except for age. Mortality was significantly higher in the sarcopenic group (85.3% vs. 66.2%; p = 0.042). Multivariable regression analysis identified continuous renal replacement therapy and sarcopenia as independent predictors of mortality. Sarcopenia, as indicated by psoas or pectoralis muscle area, is a significant predictor of increased mortality following VA-ECMO implantation, suggesting its potential use for enhanced risk stratification.
- Open Access
- 1 December 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (12) , 8173-8183
Long-term outcomes of common carotid artery cannulation for elective aortic surgery—a follow-up study
Background: The selection of the cannulation site for elective aortic surgery is mostly an individual choice based on the surgeon’s experience and the surgical strategy. We evaluated the long-term outcomes of right common carotid artery (CCA) cannulation using a side graft to establish unilateral selective antegrade cerebral perfusion (uSACP). Methods: We reviewed the records of 343 patients who underwent elective ascending aortic or aortic arch surgery between 2013 and 2020. One hundred aortic procedures were performed using the right CCA as the sole arterial cannulation site under moderate hypothermic circulatory arrest (MHCA). Cross-validated least absolute shrinkage and selection operator (LASSO) and stepwise Cox regression were applied to model the effects of cannulation sites on adverse outcomes. Kaplan-Meier analysis compared mortality in the treatment group with that in the general population. Results: The mean patient age was 65.9±9.5 years (81% male). The mean MHCA temperature was 27.1±5.1 ℃, and the average uSACP duration was 13.6±7.7 minutes. The early mortality and stroke rates were 1% and 4%, respectively. After a median of 5.4 follow-up years, seven patients suffered stroke, with 92% survival at 6 years, similar to an age- and gender-matched general population (log-rank P=0.50). Multivariable analysis revealed that age at surgery was the only significant predictor of late stroke or death [hazard ratio (HR) =1.083; P=0.01; c-index 0.683). Control Doppler ultrasound examination after a median of 2.3 years found no evidence of injury or dissection of the right CCA. Conclusions: Cannulation of the right carotid artery is a safe, feasible, and practical adjunct technique for proximal aortic surgery that generates comparable short- and long-term results. Careful patient selection and techniques are essential to minimize risk.
- 1 December 2024
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 16 (12) , 8173-8183
Open AccessLong-term outcomes of common carotid artery cannulation for elective aortic surgery—a follow-up study
Background: The selection of the cannulation site for elective aortic surgery is mostly an individual choice based on the surgeon’s experience and the surgical strategy. We evaluated the long-term outcomes of right common carotid artery (CCA) cannulation using a side graft to establish unilateral selective antegrade cerebral perfusion (uSACP). Methods: We reviewed the records of 343 patients who underwent elective ascending aortic or aortic arch surgery between 2013 and 2020. One hundred aortic procedures were performed using the right CCA as the sole arterial cannulation site under moderate hypothermic circulatory arrest (MHCA). Cross-validated least absolute shrinkage and selection operator (LASSO) and stepwise Cox regression were applied to model the effects of cannulation sites on adverse outcomes. Kaplan-Meier analysis compared mortality in the treatment group with that in the general population. Results: The mean patient age was 65.9±9.5 years (81% male). The mean MHCA temperature was 27.1±5.1 ℃, and the average uSACP duration was 13.6±7.7 minutes. The early mortality and stroke rates were 1% and 4%, respectively. After a median of 5.4 follow-up years, seven patients suffered stroke, with 92% survival at 6 years, similar to an age- and gender-matched general population (log-rank P=0.50). Multivariable analysis revealed that age at surgery was the only significant predictor of late stroke or death [hazard ratio (HR) =1.083; P=0.01; c-index 0.683). Control Doppler ultrasound examination after a median of 2.3 years found no evidence of injury or dissection of the right CCA. Conclusions: Cannulation of the right carotid artery is a safe, feasible, and practical adjunct technique for proximal aortic surgery that generates comparable short- and long-term results. Careful patient selection and techniques are essential to minimize risk.
- Open Access
- 20 June 2023
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 23 (1) , 1-8
The completeness of the left atrial appendage amputation during routine cardiac surgery
Left atrial appendage (LAA) is the origin of most heart thrombi which can lead to stroke or other cerebrovascular event in patients with non-valvular atrial fibrillation (AF). This study aimed to prove safety and low complication rate of surgical LAA amputation using cut and sew technique with control of its effectiveness. 303 patients who have undergone selective LAA amputation were enrolled in the study in a period from 10/17 to 08/20. The LAA amputation was performed concomitant to routine cardiac surgery on cardiopulmonary bypass with cardiac arrest with or without previous history of AF. The operative and clinical data were evaluated. Extent of LAA amputation was examined intraoperatively by transoesophageal echocardiography (TEE). Six months in follow up, the patients were controlled regarding clinical status and episodes of strokes. Average age of study population was 69.9 ± 19.2 and 81.9% of patients were male. In only three patients was residual stump after LAA amputation larger than 1 cm with average stump size 0.28 ± 0.34 cm. 3 patients (1%) developed postoperative bleeding. Postoperatively 77 (25.4%) patients developed postoperative AF (POAF), of which 29 (9.6%) still had AF at discharge. On 6 months follow up only 5 patients had NYHA class III and 1 NYHA class IV. Seven patients reported with leg oedema and no patient experienced any cerebrovascular event in early postoperative follow up. LAA amputation can be performed safely and completely leaving minimal to no LAA residual stump.
- 20 June 2023
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 23 (1) , 1-8
Open AccessThe completeness of the left atrial appendage amputation during routine cardiac surgery
Left atrial appendage (LAA) is the origin of most heart thrombi which can lead to stroke or other cerebrovascular event in patients with non-valvular atrial fibrillation (AF). This study aimed to prove safety and low complication rate of surgical LAA amputation using cut and sew technique with control of its effectiveness. 303 patients who have undergone selective LAA amputation were enrolled in the study in a period from 10/17 to 08/20. The LAA amputation was performed concomitant to routine cardiac surgery on cardiopulmonary bypass with cardiac arrest with or without previous history of AF. The operative and clinical data were evaluated. Extent of LAA amputation was examined intraoperatively by transoesophageal echocardiography (TEE). Six months in follow up, the patients were controlled regarding clinical status and episodes of strokes. Average age of study population was 69.9 ± 19.2 and 81.9% of patients were male. In only three patients was residual stump after LAA amputation larger than 1 cm with average stump size 0.28 ± 0.34 cm. 3 patients (1%) developed postoperative bleeding. Postoperatively 77 (25.4%) patients developed postoperative AF (POAF), of which 29 (9.6%) still had AF at discharge. On 6 months follow up only 5 patients had NYHA class III and 1 NYHA class IV. Seven patients reported with leg oedema and no patient experienced any cerebrovascular event in early postoperative follow up. LAA amputation can be performed safely and completely leaving minimal to no LAA residual stump.
- Open Access
Benefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation
Background: The benefit of the combined use of an intra-aortic balloon pump (IABP) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) for postcardiotomy shock remains unclear. We aimed to analyse the potential benefits and safety of combining these two devices. Methods: We enrolled 200 patients treated with either VA-ECMO only or in combination with IABP (ECMO-I group) between January 2012 and January 2021. To adjust the patients’ backgrounds, we used propensity score matching for additional analyses, resulting in 57 pairs. The primary endpoint was 30-day survival. Secondary endpoints included successful weaning and complication rates. We also analysed hemodynamic parameters in both groups. Results: After propensity score matching, 30-day survival was better in the ECMO-I group (log-rank p = 0.004). The ECMO-I and ECMO-only groups differed regarding the secondary endpoints, including successful weaning (50.9% and 26.3%, respectively; p = 0.012) and the need for continuous renal replacement therapy (28.1% and 50.9%, p = 0.021). Complication rates were not statistically different between the two groups. Conclusion: Compared to VA-ECMO alone, the combined use of VA-ECMO and IABP is beneficial regarding 30-day survival in selected patients with postcardiotomy shock; successful ECMO weaning and freedom from renal replacement therapy is more common in patients supported with VA-ECMO plus IABP.
Open AccessBenefits of Intra-Aortic Balloon Pump Support in Patients with Postcardiotomy Shock Requiring Venoarterial Extracorporeal Membrane Oxygenation
Background: The benefit of the combined use of an intra-aortic balloon pump (IABP) and venoarterial extracorporeal membrane oxygenation (VA-ECMO) for postcardiotomy shock remains unclear. We aimed to analyse the potential benefits and safety of combining these two devices. Methods: We enrolled 200 patients treated with either VA-ECMO only or in combination with IABP (ECMO-I group) between January 2012 and January 2021. To adjust the patients’ backgrounds, we used propensity score matching for additional analyses, resulting in 57 pairs. The primary endpoint was 30-day survival. Secondary endpoints included successful weaning and complication rates. We also analysed hemodynamic parameters in both groups. Results: After propensity score matching, 30-day survival was better in the ECMO-I group (log-rank p = 0.004). The ECMO-I and ECMO-only groups differed regarding the secondary endpoints, including successful weaning (50.9% and 26.3%, respectively; p = 0.012) and the need for continuous renal replacement therapy (28.1% and 50.9%, p = 0.021). Complication rates were not statistically different between the two groups. Conclusion: Compared to VA-ECMO alone, the combined use of VA-ECMO and IABP is beneficial regarding 30-day survival in selected patients with postcardiotomy shock; successful ECMO weaning and freedom from renal replacement therapy is more common in patients supported with VA-ECMO plus IABP.
- Open Access
- 1 February 2022
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon Reports
- Vol. 11 (01) , e11-e13
Left Ventricular Assist Device Implantation in a Patient with Ventricular Pseudoaneurysm
Background Left ventricular assist device (LVAD) implantation after contained LV rupture (pseudoaneurysm) represents a difficult surgical problem. Case Description We describe the surgical approach for such a patient. The sewing ring was implanted utilizing a Dacron patch for reconstruction of the free wall, fibrotic LV wall remnants, and a Teflon strip giving additional support for cannula position and hemostasis. The patient had an uneventful recovery and is well 19 months after the procedure. Conclusion LV pseudoaneurysm is not a contraindication for permanent LVAD implantation.
- 1 February 2022
- Published by Georg Thieme Verlag KG in The Thoracic and Cardiovascular Surgeon Reports
- Vol. 11 (01) , e11-e13
Open AccessLeft Ventricular Assist Device Implantation in a Patient with Ventricular Pseudoaneurysm
Background Left ventricular assist device (LVAD) implantation after contained LV rupture (pseudoaneurysm) represents a difficult surgical problem. Case Description We describe the surgical approach for such a patient. The sewing ring was implanted utilizing a Dacron patch for reconstruction of the free wall, fibrotic LV wall remnants, and a Teflon strip giving additional support for cannula position and hemostasis. The patient had an uneventful recovery and is well 19 months after the procedure. Conclusion LV pseudoaneurysm is not a contraindication for permanent LVAD implantation.
- 12 November 2021
- Published by IMR Press in The Heart Surgery Forum
- Vol. 24 (6) , E1052-E1053
Fibrin Sealant Patch for the Management of Intractable Bleeding From an LVAD Apex Cannula
Background: Intractable bleeding from the apical cannulation site of a left ventricular assist device (LVAD) is a dreaded complication. Case report: A 52-year-old male suffering from dilative cardiomyopathy (DCM) with fixed pulmonary hypertension underwent reoperative LVAD implantation after previous mitral valve surgery. The patient underwent three rethoracotomies for bleeding from the apex cannulation site without achieving hemostasis. Conventional techniques and application of fibrin sealants and polymeric sealing devices did not fix the problem. The bleeding stopped after application of the EVARREST® Fibrin Sealant Patch (FSP), and he needed no further transfusions. Conclusion: This patch might become a useful tool for intractable bleeding problems in LVAD surgery.
- 12 November 2021
- Published by IMR Press in The Heart Surgery Forum
- Vol. 24 (6) , E1052-E1053
Fibrin Sealant Patch for the Management of Intractable Bleeding From an LVAD Apex Cannula
Background: Intractable bleeding from the apical cannulation site of a left ventricular assist device (LVAD) is a dreaded complication. Case report: A 52-year-old male suffering from dilative cardiomyopathy (DCM) with fixed pulmonary hypertension underwent reoperative LVAD implantation after previous mitral valve surgery. The patient underwent three rethoracotomies for bleeding from the apex cannulation site without achieving hemostasis. Conventional techniques and application of fibrin sealants and polymeric sealing devices did not fix the problem. The bleeding stopped after application of the EVARREST® Fibrin Sealant Patch (FSP), and he needed no further transfusions. Conclusion: This patch might become a useful tool for intractable bleeding problems in LVAD surgery.
- 24 December 2020
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 67 (1) , 67-73
Central Versus Peripheral Arterial Cannulation for Veno-Arterial Extracorporeal Membrane Oxygenation in Post-Cardiotomy Patients
Different arterial cannulation strategies are feasible for veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in postcardiotomy shock. We aimed to analyze potential benefits and safety of different arterial cannulation strategies. We identified 158 patients with postcardiotomy cardiogenic shock requiring VA-ECMO between 01/10 and 01/19. Eighty-eight patients were cannulated via axillary or femoral artery (group P), and 70 centrally via the ascending aorta directly or through an 8 mm vascular graft anastomosed to the ascending aorta (group C). Demographics and operative parameters were similar. Change of cannulation site for Harlequin’s syndrome or hyperperfusion of an extremity occurred in 13 patients in group P but never in group C (p = 0.001). Surgical revision of cannulation site was also encountered more often in group P than C. The need for left ventricular (LV) unloading was similar between groups, whereas surgical venting was more often implemented in group C (11.4% vs. 2.3, p = 0.023). Stroke rates, renal failure, and peripheral ischemia were similar. Weaning rate from ECMO (52.9% vs. 52.3%, p = NS) was similar. The 30 day mortality was higher in group P (60% vs. 76.1%, p = 0.029). Central cannulation for VA-ECMO provides antegrade flow without Harlequin’s syndrome, changes of arterial cannula site, and better 30 day survival. Complication rates regarding need for reexploration and transfusion requirements were similar.
- 24 December 2020
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 67 (1) , 67-73
Central Versus Peripheral Arterial Cannulation for Veno-Arterial Extracorporeal Membrane Oxygenation in Post-Cardiotomy Patients
Different arterial cannulation strategies are feasible for veno-arterial extracorporeal membrane oxygenation (VA-ECMO) in postcardiotomy shock. We aimed to analyze potential benefits and safety of different arterial cannulation strategies. We identified 158 patients with postcardiotomy cardiogenic shock requiring VA-ECMO between 01/10 and 01/19. Eighty-eight patients were cannulated via axillary or femoral artery (group P), and 70 centrally via the ascending aorta directly or through an 8 mm vascular graft anastomosed to the ascending aorta (group C). Demographics and operative parameters were similar. Change of cannulation site for Harlequin’s syndrome or hyperperfusion of an extremity occurred in 13 patients in group P but never in group C (p = 0.001). Surgical revision of cannulation site was also encountered more often in group P than C. The need for left ventricular (LV) unloading was similar between groups, whereas surgical venting was more often implemented in group C (11.4% vs. 2.3, p = 0.023). Stroke rates, renal failure, and peripheral ischemia were similar. Weaning rate from ECMO (52.9% vs. 52.3%, p = NS) was similar. The 30 day mortality was higher in group P (60% vs. 76.1%, p = 0.029). Central cannulation for VA-ECMO provides antegrade flow without Harlequin’s syndrome, changes of arterial cannula site, and better 30 day survival. Complication rates regarding need for reexploration and transfusion requirements were similar.
- Open Access
- 1 December 2020
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 12 (12) , 7227-7235
First clinical experience with the novel cold storage SherpaPakTM system for donor heart transportation
Background: The current gold standard for donor heart preservation is a three-bag-technique and storage in a cooler filled with slush ice. This technique can cause freezing injury with protein denaturation. We report our early experience with a single-use disposable device (SherpaPak™, Paragonix Technologies, MA, USA) specifically designed for sterile permanent temperature-controlled transportation of donor hearts. Methods: In this case control study with 2:1 matching we identified 21 patients after heart transplantation depending on type of organ transport (standard three-bag-technique vs. SherpaPak™). The outcome after donor heart storage in the SherpaPak™ was compared with donor heart transportation with the standard technique. Results: Since July 2018 seven patients (5 males; mean age 50.3±13.2years) underwent heart transplantation with the SherpaPak™ system. Cold ischemic time was longer in the SherpaPak™ group (207.7±23.3 vs. 181.6±21.9, P=0.027). SherpaPak™ kept the organ temperature at 5.1±0.8 °C, with an average outside temperature of 21.4±3.6 °C. Among all 21 transplanted patients four developed fatal early graft failure (28.6% vs. 21.4%, P=0.432). Over the first hours we noticed no difference in hemodynamic parameters, CK-MB levels or vasoactive-inotropic score. During first follow-up we noticed slightly better right heart function in the SherpaPak™ group (TAPSE 17.83±2.71 vs. 14.52±2.61 mm, P=0.020). We identified no positive blood cultures in the SherpaPak™ group within the first 30 days after heart transplantation. Conclusions: The SherpaPak™ provides a constant temperature during transportation with permanent monitoring, never dropping below 4 °C. Organs transported with this novel device showed a normal perioperative function.
- 1 December 2020
- Published by AME Publishing Company in Journal of Thoracic Disease
- Vol. 12 (12) , 7227-7235
Open AccessFirst clinical experience with the novel cold storage SherpaPakTM system for donor heart transportation
Background: The current gold standard for donor heart preservation is a three-bag-technique and storage in a cooler filled with slush ice. This technique can cause freezing injury with protein denaturation. We report our early experience with a single-use disposable device (SherpaPak™, Paragonix Technologies, MA, USA) specifically designed for sterile permanent temperature-controlled transportation of donor hearts. Methods: In this case control study with 2:1 matching we identified 21 patients after heart transplantation depending on type of organ transport (standard three-bag-technique vs. SherpaPak™). The outcome after donor heart storage in the SherpaPak™ was compared with donor heart transportation with the standard technique. Results: Since July 2018 seven patients (5 males; mean age 50.3±13.2years) underwent heart transplantation with the SherpaPak™ system. Cold ischemic time was longer in the SherpaPak™ group (207.7±23.3 vs. 181.6±21.9, P=0.027). SherpaPak™ kept the organ temperature at 5.1±0.8 °C, with an average outside temperature of 21.4±3.6 °C. Among all 21 transplanted patients four developed fatal early graft failure (28.6% vs. 21.4%, P=0.432). Over the first hours we noticed no difference in hemodynamic parameters, CK-MB levels or vasoactive-inotropic score. During first follow-up we noticed slightly better right heart function in the SherpaPak™ group (TAPSE 17.83±2.71 vs. 14.52±2.61 mm, P=0.020). We identified no positive blood cultures in the SherpaPak™ group within the first 30 days after heart transplantation. Conclusions: The SherpaPak™ provides a constant temperature during transportation with permanent monitoring, never dropping below 4 °C. Organs transported with this novel device showed a normal perioperative function.
- Open Access
- 22 August 2017
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 53 (2) , 475-476
Venovenous extracorporeal membrane oxygenation for the management of contralateral iatrogenic bronchus perforation during lower bilobectomy
Tracheobronchial rupture by a double-lumen endobronchial tube is a rare but life-threatening complication. We report a case of bronchial rupture during contralateral bilobectomy. Venovenous extracorporeal membrane oxygenation support was instituted via the right femoral vein and the internal jugular vein with the patient in the left lateral decubitus position. Sleeve resection of the ruptured bronchus was performed. The patient was successfully discharged home. Rapid institution of venovenous extracorporeal membrane oxygenation is helpful to manage this intraoperative complication.
- 22 August 2017
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 53 (2) , 475-476
Open AccessVenovenous extracorporeal membrane oxygenation for the management of contralateral iatrogenic bronchus perforation during lower bilobectomy
Tracheobronchial rupture by a double-lumen endobronchial tube is a rare but life-threatening complication. We report a case of bronchial rupture during contralateral bilobectomy. Venovenous extracorporeal membrane oxygenation support was instituted via the right femoral vein and the internal jugular vein with the patient in the left lateral decubitus position. Sleeve resection of the ruptured bronchus was performed. The patient was successfully discharged home. Rapid institution of venovenous extracorporeal membrane oxygenation is helpful to manage this intraoperative complication.